• Publications
  • Influence
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.
The goals of the subcommittee were to review the current practice and published evidence of medical and surgical treatment options for meibomian gland dysfunction (MGD) and to identify areas with
Tear osmolarity in the diagnosis and management of dry eye disease.
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
A new pathophysiological scheme is proposed for MGD in order to better identify the pathological mechanisms involved and to allow more efficient targeting of therapeutics, and to gain true disease status rather than being viewed as a mere dysfunction.
TFOS DEWS II iatrogenic report.
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
Conjunctival cells from patients with dry eye with moderate to severe keratoconjunctivitis sicca, with or without SS, overexpress inflammatory and apoptosis-related markers, which support the use of immunomodulatory and/or anti-inflammatory drugs in the treatment of patients with KCS.
Ocular Symptoms and Signs with Preserved and Preservative-Free Glaucoma Medications
Compared to preservedeyedrops, preservative free eyedrops are significantly less associated with ocular symptoms and signs of irritation.